Lannett Plans Seven Launches In Fiscal Year 2021
As Its Respiratory And Biosimilar Candidates ‘Remain On Track’
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
